Costantini, S.; Polo, A.; Capone, F.; Accardo, M.; Sorice, A.; Lombardi, R.; Bagnara, P.; Zito Marino, F.; Amato, M.; Orditura, M.;
et al. An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer. Cancers 2022, 14, 646.
https://doi.org/10.3390/cancers14030646
AMA Style
Costantini S, Polo A, Capone F, Accardo M, Sorice A, Lombardi R, Bagnara P, Zito Marino F, Amato M, Orditura M,
et al. An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer. Cancers. 2022; 14(3):646.
https://doi.org/10.3390/cancers14030646
Chicago/Turabian Style
Costantini, Susan, Andrea Polo, Francesca Capone, Marina Accardo, Angela Sorice, Rita Lombardi, Palmina Bagnara, Federica Zito Marino, Martina Amato, Michele Orditura,
and et al. 2022. "An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer" Cancers 14, no. 3: 646.
https://doi.org/10.3390/cancers14030646
APA Style
Costantini, S., Polo, A., Capone, F., Accardo, M., Sorice, A., Lombardi, R., Bagnara, P., Zito Marino, F., Amato, M., Orditura, M., Fratelli, M., Ciliberto, G., & Budillon, A.
(2022). An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer. Cancers, 14(3), 646.
https://doi.org/10.3390/cancers14030646
